LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Superficial Bladder Cancer · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • The University of Alabama at Birmingham Clinical Research Unit (CRU), Birmingham, Alabama, United States

  • Mayo Clinic, Scottsdale, Arizona, United States

  • Urological Associates of South Arizona, Tucson, Arizona, United States

  • Arkansas Urology, Little Rock, Arkansas, United States

  • University of California - Irvine Medical Center, Irvine, California, United States

    Contact: Study coordinator (Edward Uchio) · euchio@uci.edu
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Salmasi
  • USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Anne Schuckman) · anne.schuckman@med.usc.edu · 323-865-3700
  • Tower Urology, Los Angeles, California, United States

    Contact: Study coordinator (Terry Williams) · williamst@towerurology.com · 310-854-9898
  • Om Research, San Diego, California, United States

    Contact: Study coordinator (Alanna Gavriushina) · Alanna.gavriushina@uniohp.com · 858-430-1101
    Contact: Study coordinator (Katayune Golshan) · Katayune.golshan@uniohp.com
  • Colorado Clinical Research, Lakewood, Colorado, United States

  • The George Washington Medical Faculty Associates, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Michael Whalen) · mwhalen@mfa.gwu.edu · 202-741-2798
  • University of Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Kethandapatti Balaji) · kc.balaji@jax.ufl.edu · 904-244-7340
  • Sylvester Comprehensive Cancer Center / University of Miami Hospital and Clinics, Miami, Florida, United States

  • Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Shreyas Joshi) · shreyas.joshi@emory.edu · 404-778-4898
  • Georgia Cancer Center at Augusta University, Augusta, Georgia, United States

  • Urology of Indiana, Greenwood, Indiana, United States

  • University of Kansas Medical Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Faith Rahman) · frahman2@kumc.edu · 913-588-2502
    Contact: Study coordinator (Laura Mitchell) · Lmitchell11@kumc.edu · 913-574-2854
  • John Hopkins Hospital, Baltimore, Maryland, United States

  • Chesapeake Urology Research Associates, Hanover, Maryland, United States

    Contact: Study coordinator (Rian Dickstein) · rdickstein@cua.md
  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Mark Preston) · MPRESTON@BWH.HARVARD.EDU
    Contact: Study coordinator (Saachi Pawa) · bwhurologyrcs@partners.org · 617-525-8793
  • Henry Ford Health System, Detroit, Michigan, United States

    Contact: Study coordinator (Johar Raza, MD) · jraza1@hfhs.org · 716-697-0305
  • Corewell Health Medical Group and Spectrum Health Hospitals, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Conrad Tobert) · 616-267-7333
  • University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Marissa Twedt) · twedt050@umn.edu · 612-626-6661
    Contact: Study coordinator (Joseph Zabell) · zabe0034@umn.edu
  • Mayo Clinic, Rochester, Minnesota, United States

    Shah
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Packiam
  • New Jersey Urology, LLC, Voorhees Township, New Jersey, United States

    Contact: Study coordinator (Gordon Brown) · gbrown@njurology.com
  • Albany Medical College, Albany, New York, United States

  • Roswell Park Cancer Institute, Buffalo, New York, United States

  • Mount Sinai Medical Center, New Haven, New York, United States

    Contact: Study coordinator (John Sfakianos) · john.sfakianos@mountsinai.or
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States

  • Associated Medical Professionals of NY,, Syracuse, New York, United States

  • UNC Chapel Hill Hospital, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Marc Bjurlin) · marc_bjurlin@med.unc.edu · 919-966-8217
  • Duke Health - Duke Cancer Center, Durham, North Carolina, United States

  • Associated Urologists of North Carolina, Raleigh, North Carolina, United States

    Contact: Study coordinator (Mark Jalkut) · mjalkut@gmail.com · 919-782-1255
  • University of Cincinnati Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Mohammed Kamel) · kamelme@ucmail.uc.edu · 513-558-0983
  • Central Ohio Urology Group, Gahanna, Ohio, United States

  • Clinical Research Solutions - Helios Clinical Research, Middleburg Heights, Ohio, United States

    Contact: Study coordinator (Kara Lasorella) · kara.lasorella@heliosclinical.com · 440-340-9010
  • Oregon Health & Science University (OHSU), Portland, Oregon, United States

    Contact: Study coordinator (J Liu) · jenj@ohsu.edu · 610-659-7113
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States

  • Carolina Urologic Research Center, LLC, Myrtle Beach, South Carolina, United States

    Contact: Study coordinator (Neal Shore) · nshore@auclinics.com · 843-449-1010
  • Urology Associates, P.C., Nashville, Tennessee, United States

    Jayram
  • Vanderbilt Univerity Medical Center, Nashville, Tennessee, United States

    Chang
  • Urology Austin, Austin, Texas, United States

  • UT Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Jose Santoyo) · jose.santoyo@utsouthwestern.edu · 214-645-8764
    Contact: Study coordinator (Yair Lotan) · Yair.Lotan@UTSouthwestern.edu
  • Houston Metro Urology, Houston, Texas, United States

    Gelpi-Hammerschmidt
  • Houston Methodist Hospital - Department of Urology, Houston, Texas, United States

    Contact: Study coordinator (Taliah Muhammad) · tnmuhammad@houstonmethodist.org · 346-238-4523
  • University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Ashish Kamat, MD) · akamat@mdanderson.org · 713-792-3250
  • Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States

  • University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Christine Ibilibor) · ci5d@uvahealth.org
  • Froedtert Hospital / Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Scott Johnson) · scjohnson@mcw.edu · 414-955-0867
  • Sydney Adventist Hospital, Wahroonga, New South Wales, Australia

  • Gold Coast University Hospital, Southport, Queensland, Australia

  • Icon Cancer Center Windsor Gardens, Windsor Gardens, South Australia, Australia

  • Prostate Cancer Centre, Calgary, Alberta, Canada

  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada

  • Nova Scotia Health Authority, Halifax, Nova Scotia, Canada

    Contact: Study coordinator (Ricardo Rendon) · Ricardo.Rendon@nshealth.ca
    Contact: Study coordinator (Robin Simpson) · robin.simpson@nshealth.ca
  • University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  • McGill University Health Center - Glen site, Montreal, Quebec, Canada

    Contact: Study coordinator (W Kassouf) · wassim.kassouf@mcgill.ca · 514-934-1934
    Contact: Study coordinator (K Jaureguisanchez) · Karla.Jaureguisanchez@muhc.mcgill.ca · 514-934-1934
  • CHUM Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada

  • CHU d'Angers, Angers, France

  • CHU Bordeaux Pellegrin, Bordeaux, France

  • lnstitut Bergonie 229 Cour de l'Argonne, Bordeaux, France

  • CHU de Lille, Lille, France

  • Hospices Civils de Lyon, Lyon, France

  • Hopital Bichat Claude-Bernard, Paris, France

  • CHU de Rauen- Hopital Charles Nicolle, Rouen, France

  • Klinik fur Urologie, Uro-Onkologie, spezielle urologische und Roboter-assistierte Chirurgie Universitatsklinikum Koln (AOR), Cologne, Germany

  • Urologicum Duisburg, Duisburg, Germany

  • Universitaetsklinikum Erlangen, Erlangen, Germany

  • Urologie Neandertal Mettmann, Mettmann, Germany

  • Studienpraxis Urologie, Nürtingen, Germany

  • Universitaetsklinikum Tubingen, Tübingen, Germany

  • Clinic Unit of Urology, IRCCS Ospedale San Raffaele, Milan, MI, Italy

  • Istituto Europeo di Oncologia, Milan, Italy

  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy

  • Fondazione Policlinico Universitario "A.Gemelli" IRCCS, Largo, Rome, Italy

  • Azienda Ospedaliero-Universitaria Sant'Andrea, Rome, Italy

  • UOC Urologia, IFO- lstituto Tumori "Regina Elena", Rome, Italy

  • Ospedelae Molinette San Giovanni Battista Di Torino, Torino, Italy

  • Seoul National University Bundang Hospital, Seongnam, Gyunggi-do, South Korea

  • Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • The Catholic University of Korea, Soul St. Mary's Hospital, Seoul, South Korea

  • IOB - Hospital Quironsalud Barcelona, Barbera Del Valles, Spain

  • Fundacio Puigvert, Barcelona, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Hospital Germans Trias i Pujol, Barcelona, Spain

  • Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain

  • Hospital General Universitario Gregorio Maranon, Madrid, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital Quironsalud Madrid (Next Oncology), Madrid, Spain

  • Hospital Universitario Infanta Sofia, Madrid, Spain

  • Hospital General Universitario Morales Meseguer, Murcia, Spain

  • Hospital Universitario Marqués de Valdecilla,, Santander, Spain

  • Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan

  • China Medical University Hospital, Taichung, Taiwan

  • Taichung Veterans General Hospital, Taichung, Taiwan

  • Chi Mei Medical Center, Tainan, Taiwan

  • National Taiwan University Hospital, Taipei, Taiwan

  • The Royal Marsden NHS Foundation Trust, London, United Kingdom

מובילי המחקר
  • Christine Tosone, Ms, RAC

    Study Director

    enGene, Inc.